SMVLX
Smead Value Fund
1W: -1.4%
1M: -5.3%
3M: +1.7%
YTD: +17.2%
1Y: +16.5%
3Y: +46.0%
5Y: +55.8%
$97.29
+0.28 (+0.29%)
Weekly Expected Move ±1.6%
$94
$95
$97
$99
$100
Portfolio Health Summary
IS Overall Score
53.3
★★★★★
Altman Z-Score
2.72
Grey Zone
Weight Coverage
89%
of portfolio analyzed
Holdings Matched
26
with fundamental data
InsiderStreet Scorecard
★★★★★
53.3
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
2.72
Grey Zone (1.81–2.99)
Piotroski F-Score
6.2 / 9
Moderate
Beneish M-Score
15.47
Possible Manipulator
Credit Score
—
Earnings Quality
74.7 / 100
Portfolio Valuation
P/E
13.87x
P/B
2.22x
P/S
1.84x
EV/EBITDA
14.53x
EV/Revenue
3.41x
P/FCF
10.55x
P/OCF
8.90x
PEG
3.66x
Earnings Yield
7.21%
FCF Yield
9.48%
OCF Yield
11.24%
Median P/E
14.49x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+13.8%
Net Income
+26.6%
EPS
+29.0%
FCF
+61.1%
EBITDA
+14.0%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+5.9%
Rev CAGR 5Y
+9.7%
EPS CAGR 3Y
+3.8%
EPS CAGR 5Y
+18.6%
FCF CAGR 3Y
+5.4%
FCF CAGR 5Y
+15.5%
EBITDA CAGR 3Y
+6.4%
EBITDA CAGR 5Y
+11.3%
Payout Ratio
49.66%
Buyback Yield
4.10%
Dividend Yield
2.04%
Total Shareholder Return
5.26%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$97.01
Median 1Y
$107.05
5th Pctile
$75.17
95th Pctile
$152.66
Ann. Volatility
21.6%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 13.87 |
| Portfolio P/B | 2.22 |
| Portfolio P/S | 1.84 |
| EV/EBITDA | 14.53 |
| EV/Revenue | 3.41 |
| P/FCF | 10.55 |
| P/OCF | 8.90 |
| PEG | 3.66 |
| Earnings Yield | 7.21% |
| FCF Yield | 9.48% |
| OCF Yield | 11.24% |
| Median P/E | 14.49 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 54.14% |
| Operating Margin | 16.76% |
| Net Margin | 13.21% |
| FCF Margin | 12.79% |
| ROE | 16.25% |
| ROA | 2.08% |
| ROIC | 11.49% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 1.59 |
| Debt/Assets | 0.20 |
| Net Debt/EBITDA | 1.10 |
| Interest Coverage | 1.43 |
| Current Ratio | 0.61 |
| Quick Ratio | 0.58 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 13.81% |
| Net Income Growth | 26.63% |
| EPS Growth | 29.02% |
| FCF Growth | 61.05% |
| EBITDA Growth | 13.96% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 5.92% |
| Revenue CAGR 5Y | 9.69% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 3.79% |
| EPS CAGR 5Y | 18.65% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 5.40% |
| FCF CAGR 5Y | 15.53% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 6.39% |
| EBITDA CAGR 5Y | 11.34% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 2.42% |
| Net Income CAGR 5Y | 15.81% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 53.3 |
| IS Profitability | 56.7 |
| IS Balance Sheet | 53.0 |
| IS Earnings Quality | 74.7 |
| IS Growth | 49.8 |
| IS Value | 63.5 |
| IS Momentum | 68.7 |
| IS Safety | 61.1 |
| IS Quality | 66.4 |
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 6.22 |
| Beneish M-Score | 15.47 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 2.04% |
| Payout Ratio | 49.66% |
| Buyback Yield | 4.10% |
| Total Shareholder Return | 5.26% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.664 |
| Earnings Stability | 0.282 |
| Earnings Persistence | 0.724 |
| Margin Stability | 0.759 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | 14.49 |
| Median P/B | 2.41 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 89.07% |
| Holdings Matched | 26 |
| Total Holdings | 27 |